ABVX

ABIVAX
ABVX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€4.51B
EV
€4.51B
Shares Outstanding
76.46M
Beta
0.07

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€57.43
P/E 2025E
-
P/Revenue 2025E
226.72x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ABIVAX Société Anonyme

gainify
ABVX

ABIVAX Société Anonyme

ABVX

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead ...

Sector

Healthcare

Industry

Biotechnology

CEO

de Garidel, Marc M.

Employees

69

IPO Date

2015-06-26

Headquarters

7-11 boulevard Haussmann, Paris, Ile-de-France, 75009, France

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.